Dr Andrew Cox earned his received his PhD from the University of Otago, New Zealand. He then undertook postdoctoral training at Brigham and Women’s Hospital, Harvard Medical School. In 2016, Dr Cox became a group leader in the Organogenesis and Cancer Program at the Peter MacCallum Cancer Centre and holds a joint appointment in the Department of Biochemistry and Pharmacology at the University of Melbourne. His laboratory uses zebrafish as a model system to elucidate pathways involved in liver regeneration and liver cancer. A central theme of his work is to understand how molecular pathways reprogram metabolism to fuel growth.